Publications by authors named "Mohan Bala"

41Publications

Increased risk of brain metastases in ovarian cancer patients with BRCA mutations.

Gynecol Oncol 2019 06 12;153(3):568-573. Epub 2019 Mar 12.

Harvard Medical School, Hematology/Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.03.004DOI Listing
June 2019

The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology.

Expert Rev Pharmacoecon Outcomes Res 2015 19;15(6):931-40. Epub 2015 Oct 19.

a Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies , Tufts Medical Center , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2015.1102633DOI Listing
July 2016

Impact of psoriasis on patients' work and productivity: a retrospective, matched case-control analysis.

Am J Clin Dermatol 2009 ;10(6):407-10

Johnson & Johnson Pharmaceutical Services, LLC, Malvern, Pennsylvania 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11310440-000000000-00000DOI Listing
December 2009

The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.

J Am Acad Dermatol 2009 Sep;61(3):405-10

Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S019096220900235
Publisher Site
http://dx.doi.org/10.1016/j.jaad.2009.02.015DOI Listing
September 2009

Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations.

J Drugs Dermatol 2008 Dec;7(12):1137-46

Psoriasis Research Unit, Baylor Research Institute, Dallas,TX, USA.

View Article

Download full-text PDF

Source
December 2008

Psoriasis: cardiovascular risk factors and other disease comorbidities.

J Drugs Dermatol 2008 Apr;7(4):373-7

Centocor, Inc, Malvern, PA 19355, USA.

View Article

Download full-text PDF

Source
April 2008

Systemic sclerosis prevalence and comorbidities in the US, 2001-2002.

Curr Med Res Opin 2008 Apr;24(4):1157-66

Johnson & Johnson Pharmaceutical Services, Malvern, PA 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/030079908x280617DOI Listing
April 2008

Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis.

Arthritis Rheum 2008 Apr;59(4):510-4

Centocor Research and Development, Malvern, Pennsylvania 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.23541DOI Listing
April 2008

Association of anemia and physical disability among patients with rheumatoid arthritis.

J Rheumatol 2007 Nov 15;34(11):2177-82. Epub 2007 Oct 15.

Centocor Research and Development Inc., 200 Great Valley Parkway, Malvern, PA 19355, USA.

View Article

Download full-text PDF

Source
November 2007

Presenting results of probabilistic sensitivity analysis: the incremental benefit curve.

Health Econ 2008 Mar;17(3):435-40

Outcomes Research, Centocor Research & Development, Inc., Malvern, PA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hec.1274
Publisher Site
http://dx.doi.org/10.1002/hec.1274DOI Listing
March 2008

Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis.

Eur J Dermatol 2007 Sep-Oct;17(5):381-6. Epub 2007 Aug 2.

Department of Dermatology, Georg-August University; Von-SieboldStrasse 3, 37075, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/ejd.2007.0234DOI Listing
January 2008

Overview of the pharmacoeconomics of pharmacogenetics.

Pharmacogenomics 2006 Dec;7(8):1175-84

Proprius Pharmaceuticals, 12264 El Camino Real, Suite 300, San Diego, CA 92130-3062, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.7.8.1175DOI Listing
December 2006

Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

J Rheumatol 2006 Nov 1;33(11):2167-72. Epub 2006 Sep 1.

Centocor Inc., Malvern, PA 19335, USA.

View Article

Download full-text PDF

Source
November 2006

Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis.

J Rheumatol 2006 Nov 1;33(11):2254-9. Epub 2006 Sep 1.

Division of Rheumatology, Allergy and Immunology, University of California at San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/33/11/2254.full.pdf
Web Search
November 2006

Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic concepts.

Pharmacoeconomics 2006 ;24(4):345-54

Centocor Inc., Malvern, Pennsylvania 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00019053-200624040-00005DOI Listing
June 2006

Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease.

Gastroenterology 2005 Apr;128(4):862-9

Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2005.01.048DOI Listing
April 2005

Unemployment and disability in patients with moderately to severely active Crohn's disease.

J Clin Gastroenterol 2005 May-Jun;39(5):390-5

University of Western Ontario, Robarts Research Institute, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jcge/2005/05000/Unemployment_an
Web Search
http://dx.doi.org/10.1097/01.mcg.0000159220.70290.41DOI Listing
August 2005

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.

J Am Acad Dermatol 2004 Oct;51(4):534-42

University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S019096220400742
Publisher Site
http://dx.doi.org/10.1016/j.jaad.2004.02.021DOI Listing
October 2004

Health economic analysis of new interventions: are we asking the right questions?

Authors:
Mohan V Bala

Expert Rev Pharmacoecon Outcomes Res 2004 Aug;4(4):365-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.4.4.365DOI Listing
August 2004

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.

Clin Gastroenterol Hepatol 2004 Jul;2(7):542-53

Department of Gastroenterology and Nutrition, University of Chicago Medical Center, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1542-3565(04)00238-1DOI Listing
July 2004

Pharmacogenomics and the evolution of healthcare : is it time for cost-effectiveness analysis at the individual level?

Pharmacoeconomics 2004 ;22(8):495-8

Centocor Inc., Malvern, Pennsylvania 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00019053-200422080-00002DOI Listing
August 2004

Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid arthritis.

J Rheumatol 2004 May;31(5):849-55

Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, University of California at San Diego, La Jolla, California 92093, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/31/5/849.full.pdf
Web Search
May 2004

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.

Am J Gastroenterol 2004 Jan;99(1):91-6

Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Division of Gastroenterology, Philadelphia, Pennsylvania 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1572-0241.2003.04010.xDOI Listing
January 2004

The effects of infliximab maintenance therapy on health-related quality of life.

Am J Gastroenterol 2003 Oct;98(10):2232-8

Robarts Research Institute, University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1111/j.1572-0241.2003.076
Publisher Site
http://dx.doi.org/10.1111/j.1572-0241.2003.07674.xDOI Listing
October 2003

Infliximab improves quality of life in patients with Crohn's disease.

Inflamm Bowel Dis 2002 Jul;8(4):237-43

Department of Medicine, Division of Gastroenterology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00054725-200207000-00001DOI Listing
July 2002

Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses.

Value Health 2002 Jul-Aug;5(4):338-46

Centocor, Inc., Malvern, Pennsylvania 19355, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1524-4733.2002.54134.xDOI Listing
April 2005

Economic value of thrombolysis with adjunctive abciximab in patients with subacute peripheral arterial occlusion.

Pharmacoeconomics 2002 ;20(3):203-13

Division of Diagnostic Radiology, Department of Radiology, University of Tuebingen, Dr. Eberhard-Karls-University, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00019053-200220030-00006DOI Listing
June 2002

Application of cost-effectiveness analysis to multiple products: a practical guide.

Am J Manag Care 2002 Mar;8(3):211-8

Outcomes Research, Centocor, Inc, Malvern, PA 19355, USA.

View Article

Download full-text PDF

Source
March 2002